NVO - Novo Nordisk A/S

NYSE - Nasdaq Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts2244
Avg. Estimate1.241.334.995.62
Low estimate1.181.264.785.27
High estimate1.31.395.276.27
Year ago EPS0.780.913.544.99
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts1144
Avg. Estimate8.08B8.55B31.78B36.77B
Low estimate8.08B8.55B30.82B34.75B
High estimate8.08B8.55B33.32B40.5B
Year ago sales5.65B6.53B25.66B31.78B
Sales growth (year/est)43.00%30.90%23.80%15.70%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS0.740.90.851.24
Actual EPS0.780.910.871.26
Difference0.040.010.020.02
Surprise %5.40%1.10%2.40%1.60%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate1.241.334.995.62
7 days ago1.241.334.985.65
30 days ago1.271.335.035.57
60 days ago1.21.274.745.2
90 days ago1.091.194.655.16
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/A11
Up last 30 daysN/A112
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesNVOIndustrySector(s)S&P 500
Current qtr.59.00%N/AN/AN/A
Next qtr.46.20%N/AN/AN/A
Current year41.00%N/AN/AN/A
Next year12.60%N/AN/AN/A
Next 5 years (per annum)2.80%N/AN/AN/A
Past 5 years (per annum)12.63%N/AN/AN/A